Payment overview · 2025
General Payments
$231.93
10 reported records · 4 companies
Healthcare provider profile · identity verified
Michael Cilip, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CORNING, NY · NPI 1669447108
Verified facts
What the public records show
CMS Open Payments records show Michael Cilip, MD received $231.93 in general payments during 2025 across 10 reported records.
Exact Sciences Corporation accounted for 47.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 94 claims for Synthroid by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 73 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $109.60 | 47.3% | 4 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $90.51 | 39.0% | 4 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $17.72 | 7.6% | 1 | 2025 |
| Galderma Laboratories, L.P. | Unresolved — no canonical attribution shown | $14.10 | 6.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $231.93 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $109.60 | 4 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $90.51 | 4 | 2025 |
Source payment records
|
|||||
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $17.72 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
94 | 27 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
73 | 16 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 487 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 340 | 83 |
| Metoprolol Succinate | Metoprolol Succinate | 290 | 71 |
| Atorvastatin Calcium | Atorvastatin Calcium | 253 | 79 |
| Hydrochlorothiazide | Hydrochlorothiazide | 238 | 62 |
| Omeprazole | Omeprazole | 238 | 65 |
| Tamsulosin Hcl | Tamsulosin Hcl | 231 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 219 | 60 |
| Furosemide | Furosemide | 217 | 47 |
| Enalapril Maleate | Enalapril Maleate | 198 | 52 |
| Meloxicam | Meloxicam | 193 | 52 |
| Metformin Hcl Er | Metformin Hcl | 176 | 46 |
| Prednisone | Prednisone | 175 | 69 |
| Potassium Chloride | Potassium Chloride | 162 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 161 | 34 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 153 | 29 |
| Alprazolam | Alprazolam | 146 | 60 |
| Gabapentin | Gabapentin | 141 | 50 |
| Doxycycline Hyclate | Doxycycline Hyclate | 139 | 69 |
| Eliquis | Apixaban | 137 | 32 |
| Atenolol | Atenolol | 135 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 134 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 132 | 24 |
| Methylprednisolone | Methylprednisolone | 131 | 71 |
| Losartan Potassium | Losartan Potassium | 124 | 33 |
| Lisinopril | Lisinopril | 123 | 33 |
| Sertraline Hcl | Sertraline Hcl | 118 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 115 | 31 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 113 | 23 |
| Allopurinol | Allopurinol | 110 | 26 |
| Metformin Hcl | Metformin Hcl | 103 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 24 |
| Simvastatin | Simvastatin | 100 | 28 |
| Synthroid | Levothyroxine Sodium | 94 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 19 |
| Trazodone Hcl | Trazodone Hcl | 87 | 27 |
| Azithromycin | Azithromycin | 85 | 51 |
| Spironolactone | Spironolactone | 83 | 18 |
| Cefuroxime | Cefuroxime Axetil | 80 | 58 |
| Liothyronine Sodium | Liothyronine Sodium | 80 | 20 |
| Finasteride | Finasteride | 77 | 18 |
| Tramadol Hcl | Tramadol Hcl | 74 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 73 | 23 |
| Ozempic | Semaglutide | 73 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 71 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 68 | 19 |
| Ramipril | Ramipril | 68 | 19 |
| Bupropion Xl | Bupropion Hcl | 66 | 16 |
| Methocarbamol | Methocarbamol | 64 | 21 |
| Clonazepam | Clonazepam | 62 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 57 | 26 |
| Ibuprofen | Ibuprofen | 56 | 11 |
| Repaglinide | Repaglinide | 56 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 55 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 55 | 11 |
| Cephalexin | Cephalexin | 54 | 42 |
| Amoxicillin | Amoxicillin | 53 | 28 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 53 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 53 | 15 |
| Terazosin Hcl | Terazosin Hcl | 53 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 33 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 47 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 47 | 12 |
| Clonidine Hcl | Clonidine Hcl | 45 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 44 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 43 | 14 |
| Xarelto | Rivaroxaban | 43 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 42 | 14 |
| Valsartan | Valsartan | 42 | 14 |
| Cefdinir | Cefdinir | 41 | 28 |
| Irbesartan | Irbesartan | 41 | 12 |
| Jardiance | Empagliflozin | 41 | suppressed |
| Aripiprazole | Aripiprazole | 40 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 39 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | suppressed |
| Carvedilol | Carvedilol | 36 | 11 |
| Fluconazole | Fluconazole | 35 | 15 |
| Paxlovid | Nirmatrelvir/Ritonavir | 35 | 34 |
| Meclizine Hcl | Meclizine Hcl | 34 | 19 |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 33 | 13 |
| Mounjaro | Tirzepatide | 33 | suppressed |
| Nystatin | Nystatin | 33 | 16 |
| Testosterone Cypionate | Testosterone Cypionate | 33 | 14 |
| Propranolol Hcl | Propranolol Hcl | 32 | 12 |
| Topiramate | Topiramate | 32 | suppressed |
| Estradiol | Estradiol | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | 12 |
| Pentoxifylline | Pentoxifylline | 30 | suppressed |
| Pregabalin | Pregabalin | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 14 |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 28 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 25 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Lorazepam | Lorazepam | 25 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 24 | 15 |
| Famotidine | Famotidine | 23 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Cilostazol | Cilostazol | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Progesterone | Progesterone, Micronized | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | suppressed |
| Colchicine | Colchicine | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 18 | 15 |
| Sotalol | Sotalol Hcl | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | suppressed |
| Ursodiol | Ursodiol | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Memantine Hcl | Memantine Hcl | 17 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 17 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 17 | suppressed |
| Primidone | Primidone | 17 | suppressed |
| Baclofen | Baclofen | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Anastrozole | Anastrozole | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Celecoxib | Celecoxib | 14 | suppressed |
| Diazepam | Diazepam | 14 | 11 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Tadalafil | Tadalafil | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Acarbose | Acarbose | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 12 | suppressed |
| Budesonide Ec | Budesonide | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Np Thyroid | Thyroid,pork | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Piroxicam | Piroxicam | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Budesonide Dr | Budesonide | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Minoxidil | Minoxidil | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $231.93 · 10 records | Exact Sciences Corporation | BOTOX, Cologuard Collection Kit, Wegovy | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error